TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as The Trade Desk and benefit from exponential gains.

| More on:
IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The Tax-Free Savings Account (TFSA) is a popular registered account among Canadians. Launched in 2009, the TFSA encourages savings and investments, as any withdrawal from the account is exempt from Canada Revenue Agency taxes.

Canadians can hold several asset classes in a TFSA that include stocks, bonds, and mutual funds. Investors can also buy and hold equities from exchanges south of the border, to further diversify their portfolio.

Here, we look at two U.S. stocks that I believe should be a part of your TFSA portfolio in 2022.

Green Thumb Industries

The first stock on my list is Green Thumb Industries (CNSX:GTII), a U.S.-based cannabis producer valued at a market cap of US$3 billion. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities and 77 retail locations across 15 states in the U.S.

The company manufactures and distributes a portfolio of branded cannabis products. It also owns and operates a chain of retail cannabis stores called RISE, which is fast gaining traction across the country.

Due to the recent wave of legalization in the U.S., Green Thumb has managed to increase sales from US$62.5 million in 2018 to US$893.56 million in 2021. In Q2, its sales rose by 14.6% year-over-year to US$254.3 million. It has now reported eight consecutive quarters of positive GAAP (generally accepted accounting principles) net income which stood at US$24.4 million or US$0.10 per diluted share in the June quarter.

Green Thumb’s adjusted operating EBITDA (earnings before interest, tax, depreciation, and amortization) rose 17.4% to US$78.7 million in Q2, accounting for 31% of sales. In the first six months of 2022, its operating cash flow stood at US$40 million.

Analysts also expect company sales to touch US$1.6 billion in 2023, valuing the stock at a forward price to sales multiple of 2.

Green Thumb stock is down 73% from all-time highs. But its now trading at a discount of 170% compared to consensus price target estimates. Now would be a good time to consider Green Thumb stock.

The Trade Desk

One of the largest players in the programmatic advertising segment, The Trade Desk (NASDAQ:TTD) is a solid long-term bet. Down 50% from all-time highs, TTD’s stock price has still surged 1,700% since its IPO in 2016.

Several tech giants such as Meta Platforms, Snap, and Twitter reported revenue and earnings below consensus estimates in Q2 due to a challenging macro-economic environment. However, The Trade Desk’s sales rose 35% year-over-year in Q2 to US$377 million while adjusted earnings surged 11% to US$0.20 per share. Analysts forecast sales and EPS (earnings per share) at US$365 million and US$0.20 per share, respectively.

TTD’s co-founder and CEO Jeff Green commented that the company’s stellar performance in Q2 provides the management team with confidence in gaining market share across economic cycles. It also continues to invest in verticals such as identity, connected TV, retail media, and supply chain optimization.

The Trade Desk has signed several partnerships with the world’s leading broadcasters, retailers, and publishers which should drive future revenue growth.

TTD now expects revenue of US$385 million and adjusted EBITDA of US$140 million in Q3. Analysts tracking TTD stock, forecast sales to touch US$382.2 million in the September quarter.

Due to the recent sell-off, TTD stock price is trading at a discount of almost 50% compared to consensus price target estimates. Considering its future growth potential, this stock offers a great opportunity to diversify your TFSA portfolio.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends The Trade Desk. The Motley Fool recommends Green Thumb Industries.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »